• 한방재활의학과학회지
• /
• 제26권4호
• /
• pp.23-35
• /
• 2016

Objectives This systematic review is to support the effectiveness of herbal medicine for the treatment of simple obesity in adults. Methods A total of 8 electronic databases were searched in English, Chinese and Korean. Standard methodologies for the systematic review were used to search, analyze and synthesize data based on NECA's guideline for undertaking systematic review and meta-analyses for intervention. Results After screening 1781 potential articles, we identified 13 randomized controlled trials (RCTs). We conducted a meta-analysis for the study using Bangpungtongsung-san and Taeeumjowi-tang to evaluate the effectiveness of herbal medicines on weight loss compared to placebo control. Both herbs showed positive effect in weight, body mass index and waist circumference. In an analysis comparing herbal effects considering constitutions showed that proper treatment can lower adverse events. Conclusions Our results provide evidence that herbal medicine can be an effective treatment for the obesity compare to placebo or to conventional medicine without serious adverse events. Further study is needed to evaluate effectiveness of herbal medicines considering personalized treatment and its safety.

• 대한상한금궤의학회지
• /
• 제7권1호
• /
• pp.65-73
• /
• 2015

Objective : The purpose of this paper is to report the effect of Sosiho-tang gagambang on Obesity based on Shanghanlun provisions Methods : According to a disease pattern identification diagnostic system based on Shanghanlun provisions, the patient was diagnosed as Yangmyung-byung, and treated for 90 days with Soshiho-tang gagambang that Scutellariae Radix was substituted with Salviae Miltiorrhizae Radix. The result of treatment was evaluated by Body Mass Index(BMI). Results : After taking Soshiho-tang gagambang for 90 days, the patient's BMI was decreased, and the patient is cured of Obesity. Conclusions : This study suggests that the treatment based on Shanghanlun provision has efficacy on Obesity. In addition, further studies are necessary in order to discover the roles of flavor of Shanghanlun herbal decoctions, and ensure the safety of it.

• 혜화의학회지
• /
• 제13권1호
• /
• pp.345-353
• /
• 2004

This study analyzed the contents of the research papers concerning the obesity from a psychiatrical point of view. As a result, the following conclusion was drawn. 1. In obese people, negative emotions, especially depression were frequently reported. 2. Negative feelings, especially anger, anxiety, depression, induce binge eating and can lead to obesity. 3. Depression was related to the wrong body image more than to the body mass index. 4. Wrong body image affects eating attitudes, which may cause eating disorders. 5. To treat obesity or eating disorders, we must use psychosocial treatment, for example, supportive, cognitive or behavior therapy.

• 한방비만학회지
• /
• 제4권1호
• /
• pp.193-199
• /
• 2004

We experienced a female patient who was diagnosed as obesity with diabetes. From the 6th of February to the 13th of September in the year 2004 A.D., we applied herbal medication(Yukmijihwang-tang(added) etc.), low calorie diet, aerobic exercise, behavioral therapy, electrolipolysis, articular acupuncture to her. And we examined both the change of her weight, BMI, WHR, Edema test and Glucose(FBS, PP2hrs). Patient's general condition was better than before. So it could be concluded that Yukmigihwang-tang(added) can help the treatment of obesity with diabetes.

• 한국임상약학회지
• /
• 제34권1호
• /
• pp.1-20
• /
• 2024

This review examines the pivotal clinical trials that evaluated the efficacy and safety of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in the management of obesity. The reported findings underscore significant and sustained weight loss achieved with semaglutide in diverse patient groups, although gastrointestinal disorders occurred frequently, leading to therapy discontinuation. Overall, the studies demonstrated the potential of semaglutide as a therapeutic option not only for type 2 diabetes but also for obesity. The treatment landscape in obesity is evolving, as reflected in changing regulatory approvals and clinical guidelines, suggesting a paradigm shift toward personalized approaches in this chronic disease states to achieve optimal treatment outcomes for patients.

• 한방비만학회지
• /
• 제23권1호
• /
• pp.42-50
• /
• 2023

본 증례보고는 갑상선 기능 저하증을 동반한 비만 환자 2명에게 반하백출천마탕(半夏白朮天麻湯加味方)을 투여하여 각각 77일, 66일 동안의 치료기간 동안 각각 6.5 kg, 4.5 kg의 체중 감 량의 효과 및 소증의 개선을 보였으며, 증례 2의 경우 갑상선 기능의 개선 또한 관찰하였다. 이와 같이 갑상선 기능 저하증의 환자에게 단독 한약치료를 시행하여 유의미한 효과를 보였기에 이를 보고하는 바이다.

• 한국전자통신학회논문지
• /
• 제7권6호
• /
• pp.1437-1442
• /
• 2012

현대인들에게 있어 지방제거는 성인병 예방 및 미용 측면에서 큰 관심사항이지만, 지방흡입술 등 수술적 방법은 치료효과가 확실한 반면, 심각한 부작용을 초래할 수 있고, 회복기간이 길다는 단점이 있다. 따라서 본 연구에서는 현대인들의 비만 제거에 도움이 될 수 있는 비수술적 치료법들을 비교, 분석하고 최근 각광받고 있는 열전냉각 기반 치료법을 고찰한다. 그리고 최종적으로 열전냉각 비만 치료를 위한 열전냉각 기본 제어회로를 설계한 후, 가정된 히트로드에 대해 열전냉각 장치를 설계한다.

• 대한한방부인과학회지
• /
• 제37권1호
• /
• pp.75-88
• /
• 2024

Objectives: This study aimed to identify the current use of Korean medicine for obesity and its effect for women in climacteric period. Methods: We studied women aged 45-55 who visited Daejeon Korean medicine Hospital of Daejeon University to lose body weight from January 1, 2021 to December 31, 2022 via an analysis of the medical records. The treatment duration was continuous for more than 2 weeks, and a body composition was measured by Inbody 770 at 2 to 4 weeks after the first visit. Results: 28 patients were finally selected and their average age was 49.32±3.38 years. Based on the body mass index (BMI) classification, 19 were in the 1st obesity group, 5 in the 2nd obesity group, 3 in the overweight group and 1 in the normal group. Patients usually complained comcomitant symptoms, and the symptoms of menopausal disorder was the most frequent. The average treatment duration was 3.68±0.67 weeks and the average treatment frequency was 3.93±0.98 times. All patients took herbal medicines Gambi-tang and 23 took modified fasting therapy including Gamro-su. 14 were treated by whole body far-infrared therapy and 6 were gotten partial obesity treatment. Among patients treated for accompanying symptoms, menopausal disorders were the most common (35.71%), and herbal medicine such as Gamisoyou-san, Hominis Placenta Pharmacopuncture, moxibustion, and cupping were used. After treatment, on average, body composition changed significantly; body weight 3.28±1.82 kg, BMI 1.36±1.04 kg/m², body fat 1.70±1.67 kg, skeletal muscle mass 0.81±0.91 kg, abdominal circumference 2.04±2.6 cm, and visceral fat area 8.91±12.83 cm². Conclusions: We analyzed general characteristics, BMI distribution, types of Korean medicine treatment and change of body composition. This study could be used as reference to provide practical data of treatment for obese women in climacteric period.

• 대한한방내과학회지
• /
• 제40권6호
• /
• pp.1294-1302
• /
• 2019

Objective: Glucagon-like peptide 1 (GLP-1), one of the gut peptide hormones, has an action to induce satiety, and its effect as an anti-obesity agent is known. Recently, it has been reported that many herbal medicines have an anti-diabetic effect through inhibition of DPP-4 enzyme and inducing of GLP-1 secretion. It is therefore suggested that GLP-1 may be effective for the treatment of obesity. In this study, we report a case of male obese patients treated with herbal medicine as a GLP-1 secretagogue. Methods: In this study, the patient took a fixed prescription of herbal medicine for 10 weeks and recorded his weight at each visit. Results: This prescription produced significant weight loss (BMI loss>5%). In the follow-up period after two weeks, the trend of weight loss was observed continuously. Conclusion: This prescription can be an alternative to ephedra herba-based obesity treatment.

• 대한한방소아과학회지
• /
• 제20권2호
• /
• pp.35-44
• /
• 2006

Objective : As today obese children have increased rapidly in Korea, the interest has been much increased. And parents concern about the effect of Herbal Medication(HM) on gaining weight. Therefore we had a retrospective study HM and obesity for children. Method : We examined medical record of 38 patients who visited to Department of Pediatrics in 00 medical center from 2002 to 2006 and took HM. Their Hight, Weight, Obesity Index(OI) were estimated at two points: before and after HM treatment. And they were divided into two groups according to the HM type and analyzed for differences of OI. Result : There were no significant changes in 38 patients's OI before and after treatment. But only one case gained over weight(OI: 21.31). OI increased slightly after treatment but there were not statistically significance. OI according to the HM type had slightly difference but there were not statistically significance. There were no connections between HM type, the number of days taking HM and changes of OI. Conclusion : On the basis of this study, we thought there were no connections between HM and obesity for children. But this study's cases are small in number so more study is need.